Outlook Therapeutics, Inc. 8-K Filing Report: Key Updates on February 14, 2025
Here's the key information extracted from the provided section of the financial report:
- Entity Information:
- Company Name: Outlook Therapeutics, Inc.
- CIK: 0001649989
- SEC File Number: 001-37759
- EIN: 38-3982704
- Address: 111 S. Wood Avenue Unit #100, Iselin, NJ 08830
- Phone Number: 609-619-3990
- Filing Details:
- Filing Type: 8-K
- Filing Date: February 14, 2025
- Context Information:
- Period: The report is for a single day, February 14, 2025.
- Currency: USD (U.S. Dollar)
- Units:
- Financial measures are reported in USD.
- Shares are also a unit of measure.
- Stock Information:
- Common Stock Ticker: OTLK
- Exchange: NASDAQ
Insights:
- The report is a Form 8-K, which typically indicates that a company is announcing significant events that shareholders should be aware of. This may include developments such as acquisitions, changes in management, or other impactful corporate events.
- The date of the report suggests it is a current event report, likely providing timely information to investors.
- The use of USD and shares indicates standard financial reporting practices, allowing for easy comparisons with other companies in the sector.
These details are crucial for investors and analysts monitoring the company’s performance and any significant developments affecting its stock and operations.